Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-01-02 @ 3:25 PM
Study NCT ID:
NCT07066995
Status:
RECRUITING
Last Update Posted:
2025-07-15
First Post:
2025-07-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Sponsor:
Essen Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-28
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-04
First Submit QC Date:
None
Study First Post Date:
2025-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-04
Last Update Post Date:
2025-07-15
Last Update Post Date Type:
ACTUAL